KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Non-cash Items (2016 - 2019)

Historic Non-cash Items for Exact Sciences (EXAS) over the last 8 years, with Q3 2019 value amounting to $1.3 million.

  • Exact Sciences' Non-cash Items fell 9902.0% to $1.3 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.3 million, marking a year-over-year decrease of 9902.0%. This contributed to the annual value of $120.8 million for FY2018, which is 2975.3% up from last year.
  • As of Q3 2019, Exact Sciences' Non-cash Items stood at $1.3 million, which was down 9902.0% from $1.4 million recorded in Q2 2019.
  • Exact Sciences' Non-cash Items' 5-year high stood at $209.2 million during Q1 2019, with a 5-year trough of $1.3 million in Q3 2019.
  • Over the past 5 years, Exact Sciences' median Non-cash Items value was $49.7 million (recorded in 2017), while the average stood at $72.4 million.
  • Per our database at Business Quant, Exact Sciences' Non-cash Items skyrocketed by 15694.16% in 2018 and then tumbled by 9902.0% in 2019.
  • Over the past 5 years, Exact Sciences' Non-cash Items (Quarter) stood at $41.1 million in 2015, then rose by 0.97% to $41.5 million in 2016, then skyrocketed by 124.34% to $93.1 million in 2017, then increased by 29.75% to $120.8 million in 2018, then tumbled by 98.96% to $1.3 million in 2019.
  • Its Non-cash Items stands at $1.3 million for Q3 2019, versus $1.4 million for Q2 2019 and $209.2 million for Q1 2019.